Bli medlem
Bli medlem

Du är här


Ossur Hf : Transactions in relation to share buyback program

Announcement from Össur
hf. No. 90/2016

Reykjavík, 7 November 2016

On 3 December 2015, Össur hf. initiated a share buy-back program, see Company
announcement no. 48/2015.

The purpose of the share buyback program is to reduce the Company's share
capital and adjust the capital structure by distributing capital to
shareholders in line with the Company's Capital Structure and Dividend
Policy. The program will end no later than 1 December 2016. The Company may
purchase up to 5,000,000 shares under the program, corresponding to 1.1% of
the current share capital. The total consideration for shares purchased under
the program shall not exceed USD 10 million (approx. DKK 70 million).

The following transactions have been made under the program in the period 31
October 2016 -04 November 2016:

| Date No. of shares Avg. purchase price DKK Transaction Value DKK |
| 31 October 2016 1,347 24.68 33,242 |
| 01 November 2016 3,170 24.61 78,005 |
| 02 November 2016 4,291 24.09 103,383 |
| 03 November 2016 684 24.16 16,522 |
| 04 November 2016 4,130 24.50 101,164 |
| Total 13,622 24.40 332,316 |
Össur has acquired 1,902,930 shares under the program at the average price of
DKK 24.67. Following the above transactions Össur's holding of own shares is
5,760,903 corresponding to 1.30% of the Company's total share capital.

The share buyback program on NASDAQ Copenhagen is carried out in accordance
with Regulation No. 596/2014 of the European Parliament and of the Council on
market abuse ("MAR"), and the Commission delegated regulation.

Contact persons:

Jón Sigurðsson, President&CEO Tel:
+354 515 1300

Sveinn Sölvason, CFO
Tel: +354 515 1300

Össur press releases by e-mail

If you wish to receive Össur press releases by e-mail please register at the
following web-site:

About Össur

Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopedics that help
people live a life without limitations. Its business is focused on improving
people's mobility through the delivery of innovative technologies within the
fields of braces, supports and prosthetic limbs. A recognized "Technology
Pioneer", Össur invests significantly in research and product development;
its award-winning designs ensuring a consistently strong position in the
market. Successful patient and clinical outcomes are further empowered via
educational programs and business solutions. Headquartered in Iceland, Össur
has major operations in the Americas, Europe and Asia, with additional
distributors worldwide.

Forward-Looking Statement

This press release includes "forward-looking statements" which involve risks
and uncertainties that could cause actual results to differ materially from
results expressed or implied by these statements. Össur hf. undertakes no
obligation and does not intend to update these forward-looking statements to
reflect events or circumstances occurring after this press release. You are
cautioned not to place undue reliance on these forward-looking statements,
which speak only as of the date of this press release. All forward-looking
statements are qualified in their entirety by this cautionary statement.

Share buy back transactions 31.10.2016-04.11.2016

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Ossur Hf via Globenewswire

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.